2024-25 Annual report
2024-25 Executive team
April 1, 2024 – March 31, 2025
Dr. Craig Earle
Chief Executive Officer
Erika Nicholson
Vice President, Cancer Systems and Innovation
Andrea Reed
Vice President, Strategic Partnerships
Shelley Tapp
Vice President, Finance and Corporate Services